Literature DB >> 1478842

Susceptibility of urinary pathogens in a Dublin teaching hospital.

R J Cunney1, R M McNally, E M McNamara, N al-Ansari, E G Smyth.   

Abstract

The range and resistance patterns of organisms causing urinary tract infections (UTI) vary with time and place. A prospective study of midstream urine (MSU) specimens, received over a 3 month period, was therefore undertaken. The antibiotic sensitivities of 528 isolates from 196 domiciliary and 332 hospitalised patients with significant bacteriuria (> 10(5) organisms/ml) were determined using the modified Stokes method. Escherichia coli accounted for 79% of domiciliary isolates and 57% in hospitalised patients. Gram positive organisms causing UTI have become increasingly common and were isolated from 8% and 15% of domiciliary and hospitalised patients respectively. Resistance levels for co-amoxiclav (Augmentin) were low (7% domiciliary, 14% hospitalised). However 46 Gram negative isolates (10%) had intermediate sensitivities to co-amoxiclav on disc testing. Breakpoint testing showed 89% of these to be sensitive at the urinary breakpoint but only 52% were sensitive at the systemic breakpoint. Forty nine percent of E. coli from hospital specimens were resistant to pipercillin, due to TEM-1 beta lactamase production. A 6% resistance level to ciprofloxacin in domiciliary E. coli is considerably higher than previous reports and gives cause for concern. Gentamicin resistance was found in 4% of Gram negative hospital isolates, a finding of some significance in the empiric treatment of septicaemia of urinary tract origin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478842     DOI: 10.1007/bf02983767

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  10 in total

1.  Bacteriuria and the diagnosis of infections of the urinary tract; with observations on the use of methionine as a urinary antiseptic.

Authors:  E H KASS
Journal:  AMA Arch Intern Med       Date:  1957-11

2.  Changes in the antibiotic sensitivities of urinary pathogens, 1971-1989.

Authors:  R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

3.  Susceptibility testing recommendations for ticarcillin/clavulanic acid in the Stokes' disc diffusion test.

Authors:  R Sutherland
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

4.  Urinary tract infection in general practice: direct antibiotic sensitivity testing as a potential diagnostic method.

Authors:  P G Scully; B O'Shea; K P Flanagan; F R Falkiner
Journal:  Ir J Med Sci       Date:  1990-04       Impact factor: 1.568

5.  Sensitivity testing of enterococci to ciprofloxacin.

Authors:  R Paton; C S Lewin; J Hood; S G Amyes
Journal:  J Antimicrob Chemother       Date:  1989-08       Impact factor: 5.790

6.  Antibiotic sensitivities of urinary pathogens, 1971-82.

Authors:  R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  1984-07       Impact factor: 5.790

7.  An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom.

Authors:  P Ispahani; N J Pearson; D Greenwood
Journal:  Q J Med       Date:  1987-05

8.  Ciprofloxacin therapy of urinary tract infections in paraplegic and tetraplegic patients: a bacteriological assessment.

Authors:  A J Stannard; S J Sharples; P M Norman; G S Tillotson
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

9.  Augmentin: laboratory studies.

Authors:  I D Farrell; P J Turner
Journal:  Scott Med J       Date:  1982       Impact factor: 0.729

10.  Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice.

Authors:  A M Abbas; V Chandra; P P Dongaonkar; P K Goel; P Kacker; N A Patel; O P Shrivastava; B Thakkar; G S Tillotson
Journal:  J Antimicrob Chemother       Date:  1989-08       Impact factor: 5.790

  10 in total
  1 in total

1.  Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997.

Authors:  I E Dyer; T M Sankary; J A Dawson
Journal:  West J Med       Date:  1998-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.